Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses liver steatosis and metabolic dysfunction-associated steatohepatitis (MASH), which can result in fibrosis and/or cirrhosis and increase the risk of hepatocellular carcinoma (HCC)
Your psychiatrist needs to know youre starting tirzepatide because the gastric emptying delay can reduce oral antidepressant bioavailability by up to 30%, potentially destabilising your mood
Successful long-term treatment of hepatic carnitine palmitoyltransferase I deficiency and a novel mutation
Maintaining controlled storage conditions is essential to preserve peptide structure, analytical purity, and chemical stability, ensuring consistent performance in experimental applications
Fifty years from now, we hope to see more therapeutic approaches based on the properties of GLP-1 and related peptides, optimised to treat patients according to their individual needs, with broader indications extending into areas beyond classical glucose-lowering therapy
Dont hesitate to reach out to us, and lets discuss the best way forward for your health